PATENT CLAIM ANALYSIS

Application Number: 15763626
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "210210"]

Abstract:
Compounds of formula (I): wherein R 1 , R 2 , W 3 , W 4 , A 1 , and A 2  are as defined in the description. Medicinal products containing the same which are useful in treating cancer, neurodegenerative disorders and metabolic disorders.

Claim (Index 43):
The compound according to  claim 38 , wherein A 2  represents a CH group.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.45714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16306941', '14435851', '14559294', '15247499', '15738186']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.795381129689858
- 35 USC 102 Novelty (BERT): 0.5257191493946232
- Combined Prediction Score: 0.7684149316603345
- Mean Citation Score: 314.096512
- Max Citation Score: 331.03336
- Similarity Product: 226.7392656687117

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test